Secretion of adiponectin, an important anti-inflammatory and insulin sensitizing adipokine, is reduced in obesity, insulin resistance and type 2 diabetes and increased by weight loss [5]. Here, ADIPOQ is linked to obesity due to melanocortin 4 receptor deficiency.